$51.40
1.81% yesterday
NYSE, May 08, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$51.40
+25.30 96.93% 1M
+27.99 119.56% 6M
+27.22 112.57% YTD
+39.25 323.05% 1Y
+47.69 1,285.44% 3Y
+41.41 414.51% 5Y
+41.60 424.49% 10Y
NYSE, Closing price Thu, May 08 2025
-0.95 1.81%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Market capitalization $11.50b
Enterprise Value $11.25b
P/E (TTM) P/E ratio 74.82
EV/FCF (TTM) EV/FCF 47.80
EV/Sales (TTM) EV/Sales 6.30
P/S ratio (TTM) P/S ratio 6.45
P/B ratio (TTM) P/B ratio 20.92
Revenue growth (TTM) Revenue growth 85.99%
Revenue (TTM) Revenue $1.78b
EBIT (operating result TTM) EBIT $115.57m
Free Cash Flow (TTM) Free Cash Flow $235.27m
Cash position $322.67m
EPS (TTM) EPS $0.69
P/E forward 79.62
P/S forward 4.90
EV/Sales forward 4.79
Short interest 30.80%
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Hims & Hers Health Inc. forecast:

5x Buy
31%
9x Hold
56%
2x Sell
13%

Analyst Opinions

16 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
31%
Hold
56%
Sell
13%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,784 1,784
86% 86%
100%
- Direct Costs 568 568
164% 164%
32%
1,217 1,217
63% 63%
68%
- Selling and Administrative Expenses 1,079 1,079
44% 44%
60%
- Research and Development Expense - -
-
-
138 138
4,622% 4,622%
8%
- Depreciation and Amortization 22 22
115% 115%
1%
EBIT (Operating Income) EBIT 116 116
959% 959%
6%
Net Profit 164 164
7,096% 7,096%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Neutral
Business Wire
about 6 hours ago
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $870,000,000 aggregate principal amount of 0.00% convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as am...
Positive
Seeking Alpha
about 19 hours ago
Personalized subscribers grew 136% YoY, reflecting a fundamental shift towards precision medicine. Despite declining gross margins, HIMS achieved 13pp of operating leverage in Q1. This is by far HIMS' best quarter to date. The markets need to put some respect on Andrew Dudum and his world-class team.
Positive
Seeking Alpha
about 21 hours ago
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo Nordisk partnership. Despite trading at a high valuation, technical indicators suggest continued short-term momentum, with potential for a pullback near February highs. The company's evolution from a telehealth startup to a health-tech giant showcases its strong growth, pr...
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,637
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today